New arthritis drug gets approval recommendation in the United States

WASHINGTON - A U.S. government advisory panel Tuesday recommended approval of the drug Actemra, promoted as a new type of treatment for rheumatoid arthritis, a painful and disabling swelling of the joints generally kept in check with medication. The Hoffmann-La Roche, Inc....More